Who founded Accolade?

Accolade was founded by Thomas K Spann in 2010.

Who are Accolade's investors?

Accolade's investors include 7wire Ventures, Accretive, LLC, Alumni Ventures, Andreessen Horowitz, Basecamp Fund, Blue Ivy Ventures, Carrick Capital Partners, Castor Ventures (an Alumni Ventures Fund) and 6 more.

How much funding has Accolade raised?

Accolade has disclosed $610.1M raised across 8 rounds.

Where is Accolade headquartered?

Accolade is headquartered in Plymouth Meeting, US.

Accolade

Plymouth Meeting, US · Founded 2010 · Delaware corporation · 14 known investors

accolade.com ↗

Accolade provides virtual healthcare services including primary care, mental health therapy, and benefits navigation for employees and their families. The platform connects members with doctors, therapists, and care advocates to simplify healthcare access and decision-making.

Digital HealthHealthtechSaaS

Founders & leadership

Accolade was founded in 2010 by Thomas K Spann.

Thomas K SpannFounder

Steve BarnesExecutive

Rajeev SinghChief Executive Officer

Debbie CohenExecutive

James C. Madden, VNamed on SEC filing

Edgar, Jr. BronfmanNamed on SEC filing

John RollinsNamed on SEC filing

Arthur H. SpiegelNamed on SEC filing

William FristNamed on SEC filing

James C. MaddenNamed on SEC filing

Jeff SmithNamed on SEC filing

Board

Michael T. YangBoard director

Investors · 14

7wire VenturesChicago · $100K – $5M

Accretive, LLCNew York

Alumni VenturesManchester · $100K – $10M

Andreessen HorowitzMenlo Park · $500K – $50Mvia Jeff Jordan · board

Basecamp FundManchester · $100K – $10M

Blue Ivy VenturesBoston

Carrick Capital PartnersSan Francisco

Castor Ventures (an Alumni Ventures Fund)

Comcast VenturesNew York · $2M – $15M

Cross Creek AdvisorsSalt Lake City

Escalate Capital PartnersAustin

Madrona Venture GroupSeattle · $2M – $10M

McKesson VenturesSan Francisco

Strawberry Creek VenturesManchester

Reported raises · per SEC filings

Form D private placements

$610.1M disclosed across 8 rounds · 2014–2021

▶$11.3MraisedOct 2021 · 1 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Patricia WadorsDirector
Elizabeth NabelDirector
Cindy KentDirector
Peter KleinDirector
Jeff JordanDirector
Robert CavanaughExecutive Officer
Michael HiltonExecutive Officer
Rajeev SinghExecutive Officer, Director
Jeffrey BrodskyDirector
Stephen BarnesExecutive Officer
Thomas J. NeffDirector
Dawn LeporeDirector

Offering amount: $12.5M
Amount sold: $11.3M
First sale: Sep 2021
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$325.3MraisedJun 2021 · 79 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Cindy KentDirector
Rajeev SinghExecutive Officer, Director
Jeff BrodskyDirector
Stephen BarnesExecutive Officer
Jeff JordanDirector
Dawn LeporeDirector
Robert CavanaughExecutive Officer
Elizabeth NabelDirector
Michael HiltonExecutive Officer
Thomas J. NeffDirector
Peter KleinDirector
Patricia WadorsDirector

Offering amount: $390.4M
Amount sold: $325.3M
First sale: Jun 2021
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$130MraisedMar 2021 · 43 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Thomas J. NeffDirector
Cindy KentDirector
J. Michael ClineDirector
Peter KleinDirector
Patricia WadorsDirector
William Frist, Sr.Director
Dawn LeporeDirector
Stephen BarnesExecutive Officer
Jeff JordanDirector
Robert CavanaughExecutive Officer
Michael HiltonExecutive Officer
Rajeev SinghExecutive Officer, Director

Offering amount: $230M
Amount sold: $130M
First sale: Mar 2021
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$20MraisedOct 2019 · 1 investors · Other Health Care

Rule 506(b)

What pandemic? Tech funding stays strong, Accolade’s IPOgeekwire.com · Jul 2020

Officers, directors & promoters on the filing

Edgar Bronfman, Jr.Director
James C. Madden, VDirector
J. Michael ClineDirector
Peter KleinDirector
Michael T. YangDirector
Thomas J. NeffDirector
Dawn LeporeDirector
Stephen BarnesExecutive Officer
Jeff JordanDirector
Rajeev SinghExecutive Officer, Director
Mike HiltonExecutive Officer
William Frist, Sr.Director
Richard EskewExecutive Officer
Robert CavanaughExecutive Officer

Offering amount: $20M
Amount sold: $20M
First sale: Oct 2019
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$27.2MraisedMar 2018 · 17 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Michael T. YangDirector
J. Michael ClineDirector
Edgar Bronfman, Jr.Director
Robert CavanaughExecutive Officer
Jeff JordanDirector
Thomas K SpannExecutive Officer, Director
James C. Madden, VDirector
Ivor HornExecutive Officer
Mark MactasDirector
Stephen BarnesExecutive Officer
Dave SwiftExecutive Officer
Thomas J. NeffDirector
Rajeev SinghExecutive Officer, Director
Elizabeth NapolitanoExecutive Officer
William Frist, Sr.Director
Richard EskewExecutive Officer
Mike HiltonExecutive Officer

Offering amount: $50M
Amount sold: $27.2M
First sale: Mar 2018
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$55MraisedAug 2016 · 4 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Jeff JordanDirector
Mark MactasDirector
Sheila BurkeDirector
James C. Madden, VDirector
Michael T. YangDirector
Thomas K SpannExecutive Officer, Director
Stephen BarnesExecutive Officer
Thomas J. NeffDirector
J. Michael ClineDirector
Edgar Bronfman, Jr.Director
William Frist, Sr.Director
Rajeev SinghExecutive Officer, Director

Offering amount: $60M
Amount sold: $55M
First sale: Jul 2016
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$38.6MraisedDec 2015 · 5 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Sheila BurkeDirector
Michael T. YangDirector
Steve BarnesExecutive Officer
Thomas J. NeffDirector
J. Michael ClineDirector
John W. RoweDirector
James C. Madden, VDirector
William Frist, Sr.Director
Mark MactasDirector
Thomas K SpannExecutive Officer, Director
Rajeev SinghExecutive Officer, Director
Debbie CohenExecutive Officer
Edgar Bronfman, Jr.Director

Offering amount: $53.6M
Amount sold: $38.6M
First sale: Jul 2015
Incorporated: Corporation, Delaware, 2010
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$2.8MraisedMay 2014 · 1 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

J. Michael ClineDirector
Edgar, Jr. BronfmanDirector
Thomas J. NeffDirector
John RollinsExecutive Officer
John W. RoweDirector
Arthur H. SpiegelDirector
William FristDirector
James C. MaddenDirector
Thomas K SpannExecutive Officer, Director
Michael T. YangDirector
Jeff SmithExecutive Officer

Offering amount: $2.8M
Amount sold: $2.8M
First sale: Apr 2014
Incorporated: Corporation, Delaware, 2010
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Accolade went on to found or lead other companies.

Drew HoustonFounderFounded Dropbox Galen SimmonsCEO & FounderFounded Direct Match

Competitors · 1

by search overlap

Transcarent93 shared keywordsTranscarent operates a generative AI-powered health and care platform that combines medical, pharmacy, and point solutions into a single member experience, helping people navigate the healthcare system and access on-demand care. It is sold to employers as a benefit to address healthcare cost, complexity, and access for their members.

Companies competing with Accolade for the same Google search keywords, organic and paid, via search-intersection analysis.

Acquisitions · 1

Early investors' stakes continue via these deals

HealthReveal

Identifies gaps in evidence-based care and guides clinicians to appropriate interventions; acquired by Accolade.

In the news

LimX Dynamics Raises Nearly $200 Million In Pre-IPO Funding To Scale Humanoid Robotspulse2.com · Jul 2026

China's DeepSeek to raise fresh capital at $74 billion valuation ahead of onshore IPO - The Economic Timesm.economictimes.com · Jul 2026

Caliber Mining’s ₹450 crore IPO opens today; raises ₹135 crore from anchor investors ahead of issuefortuneindia.com · Jul 2026

London Broker Howden Plots Giant Capital Raise on IPO Path - Bloombergbloomberg.com · Jul 2026

Space startup funding holds near record highs as SpaceX IPO draws new investors | 101 WIXX | Your Hit Music Stationwixx.com · Jul 2026

SBI Funds raises Rs 2,663 crore from anchor investors ahead of IPO - The Economic Timesm.economictimes.com · Jul 2026

What pandemic? Tech funding stays strong, Accolade’s IPOgeekwire.com · Jul 2020

Frequently asked questions

What does Accolade do?: Accolade provides virtual healthcare services including primary care, mental health therapy, and benefits navigation for employees and their families. The platform connects members with doctors, therapists, and care advocates to simplify healthcare access and decision-making.
Who founded Accolade?: Accolade was founded by Thomas K Spann in 2010.
Who are Accolade's investors?: Accolade's investors include 7wire Ventures, Accretive, LLC, Alumni Ventures, Andreessen Horowitz, Basecamp Fund, Blue Ivy Ventures, Carrick Capital Partners, Castor Ventures (an Alumni Ventures Fund) and 6 more.
How much funding has Accolade raised?: Accolade has disclosed $610.1M raised across 8 rounds.
Where is Accolade headquartered?: Accolade is headquartered in Plymouth Meeting, US.